Moreover, quercetin was reported to have the ability to improve hypertriglyceridemia, alleviate hypercholesterolemia, and elevate HDL-cholesterol in db/db mice by decreasing the expression of peroxisome proliferator-activated receptor-α (PPAR-α) and sterol regulatory element-binding protein-1c (SREBP-1c) and reducing acetyl-CoA carboxylase (ACC) activity [43]. This evidence concerns the gene SREBF1 and familial hypercholesterolemia.